Communicated by Bruce Gottlieb
Functional Characterization of Novel Mutations Affecting Survivin (BIRC5)-Mediated Therapy Resistance in Head and Neck Cancer Patients
Version of Record online: 20 DEC 2012
© 2012 Wiley Periodicals, Inc.
Volume 34, Issue 2, pages 395–404, February 2013
How to Cite
Knauer, S. K., Unruhe, B., Karczewski, S., Hecht, R., Fetz, V., Bier, C., Friedl, S., Wollenberg, B., Pries, R., Habtemichael, N., Heinrich, U.-R. and Stauber, R. H. (2013), Functional Characterization of Novel Mutations Affecting Survivin (BIRC5)-Mediated Therapy Resistance in Head and Neck Cancer Patients. Hum. Mutat., 34: 395–404. doi: 10.1002/humu.22249
Contract grant sponsors: MAIFOR; German Research Foundation FKZ KN 973/1-1; Stiftung Tumorforschung Kopf-Hals; Carl-Zeiss foundation 3ChemBioMed2 priority program.
- Issue online: 29 JAN 2013
- Version of Record online: 20 DEC 2012
- Accepted manuscript online: 15 NOV 2012 12:29PM EST
- Manuscript Accepted: 31 OCT 2012
- Manuscript Received: 1 JAN 2012
- German Research Foundation. Grant Number: FKZ KN 973/1-1;
- Stiftung Tumorforschung Kopf-Hals
- Carl-Zeiss foundation
Disclaimer: Supplementary materials have been peer-reviewed but not copyedited.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.